Advertisement

Incidentaloma

  • Jacob Moalem
  • Insoo Suh
  • Quan-Yang Duh
Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 153)

Abstract

Adrenal incidentalomas, unsuspected tumors that are discovered during radiologic procedures that are performed for unrelated causes, are found in up to 5% of all abdominal imaging studies. Once found, these lesions must be characterized according to their endocrine activity and malignant potential. Although the majority of these lesions are benign and require no surgical intervention, hormonally active tumors such as pheochromocytoma, cortisol-producing adenoma, or aldosteronoma, and primary or secondary cancers of the adrenal gland must be definitively diagnosed or excluded in all cases. Functional neoplasms, as well as isolated adrenal metastases, should be resected laparoscopically if possible. Large, locally invasive lesions that are suspected to be primary adrenocortical cancers should be resected via the open approach. Recommended follow up for apparently benign and nonfunctioning cortical adenomas includes serial imaging and biochemical testing.

Keywords

Primary Hyperaldosteronism Adrenal Tumor Adrenal Mass Laparoscopic Adrenalectomy Urinary Free Cortisol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Barwick TD, Malhotra A, Webb JA, Savage MO, Reznek RH (2005) Embryology of the adrenal glands and its relevance to diagnostic imaging. Clin Radiol 60(9):953–959CrossRefPubMedGoogle Scholar
  2. 2.
    Langman J, Sadler TW (1995) Langman’s medical embryology, 7th edn. Williams & Wilkins, BaltimoreGoogle Scholar
  3. 3.
    Avisse C, Marcus C, Patey M, Ladam-Marcus V, Delattre JF, Flament JB (2000) Surgical anatomy and embryology of the adrenal glands. Surg Clin North Am 80(1):403–415CrossRefPubMedGoogle Scholar
  4. 4.
    Souverijns G, Peene P, Keuleers H, Vanbockrijck M (2000) Ectopic localisation of adrenal cortex. Eur Radiol 10(7):1165–1168CrossRefPubMedGoogle Scholar
  5. 5.
    Geelhoed GW, Druy EM (1982) Management of the adrenal “incidentaloma”. Surgery 92(5):866–874PubMedGoogle Scholar
  6. 6.
    Mantero F, Arnaldi G (2000) Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am 29(1):107–125, ixGoogle Scholar
  7. 7.
    Kokko JP, Brown TC, Berman MM (1967) Adrenal adenoma and hypertension. Lancet 1(7488):468–470Google Scholar
  8. 8.
    Dobbie JW (1969) Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99(1):1–18CrossRefPubMedGoogle Scholar
  9. 9.
    Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460–484PubMedGoogle Scholar
  10. 10.
    Thompson GB, Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15(1):84–90CrossRefPubMedGoogle Scholar
  11. 11.
    Sutton MG, Sheps SG, Lie JT (1981) Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56(6):354–360Google Scholar
  12. 12.
    Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169(1):5–11CrossRefPubMedGoogle Scholar
  13. 13.
    Kudva YC, Sawka AM, Young WF Jr (2003) Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab 88(10):4533–4539CrossRefPubMedGoogle Scholar
  14. 14.
    Brunt LM, Moley JF (2001) Adrenal incidentaloma. World J Surg 25(7):905–913CrossRefPubMedGoogle Scholar
  15. 15.
    Aso Y, Homma Y (1992) A survey on incidental adrenal tumors in Japan. J Urol 147(6):1478–1481PubMedGoogle Scholar
  16. 16.
    Cheah WK, Clark OH, Horn JK, Siperstein AE, Duh QY (2002) Laparoscopic adrenalectomy for pheochromocytoma. World J Surg 26(8):1048–1051CrossRefPubMedGoogle Scholar
  17. 17.
    Kebebew E, Siperstein AE, Clark OH, Duh QY (2002) Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 137(8):948–951; discussion 952–943Google Scholar
  18. 18.
    Hartley L, Perry-Keene D (1985) Phaeochromocytoma in Queensland – 1970–83. Aust NZ J Surg 55(5):471–475CrossRefGoogle Scholar
  19. 19.
    Lenders JW, Pacak K, Walther MM et al (2002) Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287(11):1427–1434Google Scholar
  20. 20.
    Grumbach MM, Biller BM, Braunstein GD et al (2003) Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 138(5):424–429Google Scholar
  21. 21.
    Lee JA, Zarnegar R, Shen WT, Kebebew E, Clark OH, Duh QY (2007) Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the “subclinical” pheochromocytoma. Arch Surg 142(9):870–873; discussion 873–874Google Scholar
  22. 22.
    Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526–1540CrossRefPubMedGoogle Scholar
  23. 23.
    Catargi B, Rigalleau V, Poussin A et al (2003) Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88(12):5808–5813CrossRefPubMedGoogle Scholar
  24. 24.
    Reimondo G, Pia A, Allasino B et al (2007) Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67(2):225–229CrossRefGoogle Scholar
  25. 25.
    Ness-Abramof R, Nabriski D, Apovian CM et al (2002) Overnight dexamethasone suppression test: a reliable screen for Cushing’s syndrome in the obese. Obes Res 10(12):1217–1221CrossRefPubMedGoogle Scholar
  26. 26.
    Anderson GH Jr, Blakeman N, Streeten DH (1994) The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12(5):609–615CrossRefPubMedGoogle Scholar
  27. 27.
    Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27(3):193–202CrossRefPubMedGoogle Scholar
  28. 28.
    Glass AR, Zavadil AP III, Halberg F, Cornelissen G, Schaaf M (1984) Circadian rhythm of serum cortisol in Cushing’s disease. J Clin Endocrinol Metab 59(1):161–165CrossRefPubMedGoogle Scholar
  29. 29.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL (1985) The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing’s syndrome. J Clin Endocrinol Metab 60(3):527–535CrossRefPubMedGoogle Scholar
  30. 30.
    Orth DN (1995) Cushing’s syndrome. N Engl J Med 332(12):791–803Google Scholar
  31. 31.
    Nickelsen T, Lissner W, Schoffling K (1989) The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test. Exp Clin Endocrinol 94(3):275–280CrossRefPubMedGoogle Scholar
  32. 32.
    Qureshi AC, Bahri A, Breen LA et al (2007) The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin Endocrinol (Oxf) 66(5):632–635CrossRefGoogle Scholar
  33. 33.
    Klose M, Lange M, Rasmussen AK et al (2007) Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab 92(4):1326–1333CrossRefPubMedGoogle Scholar
  34. 34.
    Hamrahian AH, Oseni TS, Arafah BM (2004) Measurements of serum free cortisol in critically ill patients. N Engl J Med 350(16):1629–1638Google Scholar
  35. 35.
    Liddle GW (1960) Tests of pituitary–adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 20:1539–1560CrossRefPubMedGoogle Scholar
  36. 36.
    Pecori Giraldi F, Pivonello R, Ambrogio AG et al (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 66(2):251–257CrossRefGoogle Scholar
  37. 37.
    Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic–Pituitary–Adrenal Axis. J Clin Endocrinol Metab 84(2):440–448Google Scholar
  38. 38.
    Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B (1997) Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome – recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34(Pt 3):222–229PubMedGoogle Scholar
  39. 39.
    Chan KC, Lit LC, Law EL et al (2004) Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment. Clin Chem 50(4):757–759CrossRefPubMedGoogle Scholar
  40. 40.
    Mericq MV, Cutler GB Jr (1998) High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endocrinol Metab 83(2):682–684CrossRefPubMedGoogle Scholar
  41. 41.
    Read GF, Walker RF, Wilson DW, Griffiths K (1990) Steroid analysis in saliva for the assessment of endocrine function. Ann N Y Acad Sci 595:260–274CrossRefPubMedGoogle Scholar
  42. 42.
    Elamin MB, Murad MH, Mullan R et al (2008) Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 93(5):1553–1562CrossRefPubMedGoogle Scholar
  43. 43.
    Melby JC (1985) Diagnosis and treatment of primary aldosteronism and isolated hypoaldosteronism. Clin Endocrinol Metab 14(4):977–995CrossRefPubMedGoogle Scholar
  44. 44.
    Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21(4):315–318CrossRefPubMedGoogle Scholar
  45. 45.
    Mantero F, Terzolo M, Arnaldi G et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85(2):637–644Google Scholar
  46. 46.
    Conn JW (1967) Diagnosis of Normokalemic primary aldosteronism, a new form of curable hypertension. Science 158(3800):525–526Google Scholar
  47. 47.
    Conn JW, Cohen EL, Rovner DR, Nesbit RM (1965) Normokalemic primary aldosteronism. A detectable cause of curable “essential” hypertension. JAMA 193:200–206Google Scholar
  48. 48.
    Vantyghem MC, Ronci N, Provost F et al (1999) Aldosterone-producing adenoma without hypertension: a report of two cases. Eur J Endocrinol 141(3):279–285CrossRefPubMedGoogle Scholar
  49. 49.
    Bravo EL (1994) Primary aldosteronism. Issues in diagnosis and management. Endocrinol Metab Clin North Am 23(2):271–283Google Scholar
  50. 50.
    Young WF Jr, Hogan MJ, Klee GG, Grant CS, van Heerden JA (1990) Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 65(1):96–110PubMedGoogle Scholar
  51. 51.
    Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25(2):309–340CrossRefPubMedGoogle Scholar
  52. 52.
    Weingartner K, Gerharz EW, Bittinger A, Rosai J, Leppek R, Riedmiller H (1995) Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma. Case report and review of the literature. Urol Int 55(4):232–235Google Scholar
  53. 53.
    Doppman JL, Gill JR Jr (1996) Hyperaldosteronism: sampling the adrenal veins. Radiology 198(2):309–312PubMedGoogle Scholar
  54. 54.
    Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA (2004) Role for adrenal venous sampling in primary aldosteronism. Surgery 136(6):1227–1235CrossRefPubMedGoogle Scholar
  55. 55.
    Zarnegar R, Bloom AI, Lee J et al (2008) Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? J Vasc Interv Radiol 19(1):66–71CrossRefPubMedGoogle Scholar
  56. 56.
    Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171(1):201–204PubMedGoogle Scholar
  57. 57.
    Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E (2006) Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 202(3):423–430CrossRefPubMedGoogle Scholar
  58. 58.
    Terzolo M, Ali A, Osella G, Mazza E (1997) Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 132(8):914–919Google Scholar
  59. 59.
    Szolar DH, Korobkin M, Reittner P et al (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234(2):479–485CrossRefPubMedGoogle Scholar
  60. 60.
    Reinig JW, Doppman JL, Dwyer AJ, Frank J (1986) MRI of indeterminate adrenal masses. AJR Am J Roentgenol 147(3):493–496PubMedGoogle Scholar
  61. 61.
    Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175(5):1411–1415PubMedGoogle Scholar
  62. 62.
    Caoili EM, Korobkin M, Francis IR et al (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222(3):629–633CrossRefPubMedGoogle Scholar
  63. 63.
    Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F (1998) CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170(3):747–752PubMedGoogle Scholar
  64. 64.
    Al-Hawary MM, Francis IR, Korobkin M (2005) Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 19(2):277–292CrossRefPubMedGoogle Scholar
  65. 65.
    Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH (1986) Adrenal masses differentiated by MR. Radiology 158(1):81–84PubMedGoogle Scholar
  66. 66.
    Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42(12):1795–1799PubMedGoogle Scholar
  67. 67.
    Tessonnier L, Sebag F, Palazzo FF et al (2008) Does (18)F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging (11):2018–2025Google Scholar
  68. 68.
    Gagner M, Lacroix A, Prinz RA et al (1993) Early experience with laparoscopic approach for adrenalectomy. Surgery 114(6):1120–1124; discussion 1124–1125Google Scholar
  69. 69.
    Shen WT, Lim RC, Siperstein AE et al (1999) Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg 134(6):628–631; discussion 631–622Google Scholar
  70. 70.
    Fernandez-Cruz L, Saenz A, Benarroch G, Astudillo E, Taura P, Sabater L (1996) Laparoscopic unilateral and bilateral adrenalectomy for Cushing’s syndrome. Transperitoneal and retroperitoneal approaches. Ann Surg 224(6):727–734; discussion 734–726Google Scholar
  71. 71.
    Duh QY (2007) Laparoscopic adrenalectomy for isolated adrenal metastasis: the right thing to do and the right way to do it. Ann Surg Oncol 14(12):3288–3289CrossRefPubMedGoogle Scholar
  72. 72.
    Henry JF, Sebag F, Iacobone M, Mirallie E (2002) Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg 26(8):1043–1047CrossRefPubMedGoogle Scholar
  73. 73.
    Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM (1998) Can adrenal incidentalomas be safely observed? World J Surg 22(6):599–603; discussion 603–594Google Scholar
  74. 74.
    Jockenhovel F, Kuck W, Hauffa B et al (1992) Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas). J Endocrinol Invest 15(5):331–337PubMedGoogle Scholar
  75. 75.
    Staren ED, Prinz RA (1995) Selection of patients with adrenal incidentalomas for operation. Surg Clin North Am 75(3):499–509PubMedGoogle Scholar
  76. 76.
    Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M (1999) Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84(2):520–526CrossRefPubMedGoogle Scholar
  77. 77.
    Adler JT, Mack E, Chen H (2007) Isolated adrenal mass in patients with a history of cancer: remember pheochromocytoma. Ann Surg Oncol 14(8):2358–2362CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Surgery, Veterans Affairs Medical CenterUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations